Skip to content

National Hospital based Registry on Venous Thromboembolic Disorders

ââ?¬Å?Establishment of National Hospital based Registry on Venous Thromboembolic Disorders (i-RegVeD/à¤â?¹Ã Â¤â??à¥?वà¥â?¡Ã Â¤Â¦)ââ?¬? - i-RegVeD/à¤â?¹Ã Â¤â??à¥?वà¥â?¡Ã Â¤Â¦

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/09/045146
Enrollment
2000
Registered
2022-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I829- Embolism and thrombosis of unspecified vein

Interventions

None listed

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a.All Patients diagnosed with VTE: Patients will be included if they have acute deep-vein thrombosis (DVT), pulmonary embolism (PE) and/or spontaneous superficial venous thrombosis (SVT), unusual site venous thrombosis confirmed by objective tests (i.e. contrast venography, ultrasonography, impedance plethysmography or magnetic resonance, for suspected DVT; pulmonary angiography, lung scintigraphy or helical computed tomography scan, for suspected PE; ultrasonography for suspected SVT). b. All age groups c. All types of patients (including Seriously ill patients) admitted to hospital as new patients or existing patients who develop VTE/PE as complication in due course of treatment at participating site. d. Pateints enrolled in a clinical trial or on experimental therapy would also be included based on the site IEC approvals

Exclusion criteria

Exclusion criteria: a. Patients will be excluded if they are currently participating in a therapeutic clinical trial or if they will not be available for a 3-month follow-up. b. superficial venous thrombosis (SVT) arising out of iv line/cannula b.c. A diagnosed case of fat embolism due to any etiology including orthopedic complication

Design outcomes

Primary

MeasureTime frame
1. Assessment of data entry points if any modification needed and discussion with experts 2. Interim Analysis 3. Annual Progress Report 4. Second Progress Report 5. Final Progress ReportTimepoint: 1. 3 months 2. 6 months 3. 12 months 4. 24 months 5. 36 months

Secondary

MeasureTime frame
Epidemiological trends of VTE patients coming to participating hospitals for VTE managementTimepoint: 1 year

Countries

India

Contacts

Public ContactDr Heena Tabassum

ICMR

tabassum.h@icmr.gov.in9582150416

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026